Culliford Steven, Ellory Clive, Lang Hans-Jochen, Englert Heinrich, Staines Hery, Wilkins Robert
University Laboratory of Physiology, Parks Road, Oxford.
Cell Physiol Biochem. 2003;13(4):181-8. doi: 10.1159/000072420.
The majority of anion transport inhibitors tend to be non-specific. This is problematic from a research point of view as caution is required when defining pathways purely based on pharmacology. Here we have tested a range of classical and putative Cl(-) transport inhibitors on three Cl(-) carrier systems (the KCl cotransporter (KCC), the NaK2Cl cotransporter (NKCC), and the Band 3 anion exchanger (AE)) found in human erythrocytes, using radiolabel tracer experiments. The study confirms the cross-reactivity of many anion transport inhibitors. However, two compounds, H25 and H156, were found to be both potent (IC(50) values < 0.1 mM) and specific (at least 1000-fold more effective against one carrier compared to the other two) inhibitors of NKCC and AE, respectively.
大多数阴离子转运抑制剂往往是非特异性的。从研究角度来看,这是个问题,因为在单纯基于药理学定义转运途径时需要谨慎。在此,我们使用放射性标记示踪实验,对一系列经典的和假定的Cl⁻转运抑制剂在人红细胞中发现的三种Cl⁻载体系统(KCl协同转运体(KCC)、NaK2Cl协同转运体(NKCC)和带3阴离子交换体(AE))上进行了测试。该研究证实了许多阴离子转运抑制剂的交叉反应性。然而,发现两种化合物H25和H156分别是NKCC和AE的强效(IC₅₀值<0.1 mM)且特异性(对一种载体的抑制作用比对其他两种载体至少强1000倍)抑制剂。